Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma

  • The PLOS ONE Staff

There is an error in Table 2. Two cells in the row corresponding to patients under 18 years of age at diagnosis were incorrectly shifted to the left. The value “6” should appear in the “n” column and “16 (3.1–28.4)” should be listed in the “Mean months (95% CI)” column. The publisher apologizes for this error. Please see the corrected Table 2 here.

thumbnail
Download:
Table 2. Kaplan-Meier survival analyses for overall survival of all patients with osteosarcoma and for overall survival and post metastases overall survival of patients with osteosarcoma presented with metastases at diagnosis or developed metastases during treatment/follow-up.

https://doi.org/10.1371/journal.pone.0188991.t001

Reference

  1. 1. Thanapprapasr K, Nartthanarung A, Thanapprapasr D, Jinawath A (2017) pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma. PLoS ONE12(8): e0182989. https://doi.org/10.1371/journal.pone.0182989 pmid:28846700

Citation: The PLOS ONE Staff (2017) Correction: pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma. PLoS ONE 12(11): e0188991. https://doi.org/10.1371/journal.pone.0188991

Published: November 29, 2017

Copyright: © 2017 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.